Business
Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance
LOUISVILLE, Ky., April 29, 2026--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended March 31, 2026 (1Q26) versus the quarter ended March 31, 2025 (1Q25) as noted in the tables below.
About this update from Humana Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/a5417b945c3506994fe6abbcebff7d50"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NGB2hYMrsBjU8I7I1MNWhw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/a5417b945c3506994fe6abbcebff7d50","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/VleVVv_9l61zu3F1lrLoWQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/a5417b945c3506994fe6abbcebff7d50","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Reports 1Q26 earnings per share (EPS) of $9.83 on a GAAP basis, Adjusted EPS of $10.31; at the high end of the company's guidance of approximately 110 percent to 115 percent of full year (FY) 2026 Adjusted EPS","length":213,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"1Q26 Insurance segment GAAP benefit ratio of 89.4 percent, slightly favorable to management's guidance of 'just under 90 percent'; affirms FY 2026 Insurance segment benefit ratio guidance of 92.75 percent, plus or minus 25 basis points","length":247,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Affirms Adjusted FY 2026 GAAP EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $8.36' from the previous estimate of 'at least $8.89'","length":187,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Affirms FY 2026 individual Medicare Advantage (MA) membership growth of 'approximately 25 percent' over 2025; driven by new sales and improved retention from the company's customer-led benefit strategy and changes to its customer service approach","length":258,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Continued execution of strategic growth initiatives and integration of new contracts within CenterWell and state-based contracts businesses, respectively, to expand the company's national footprint","length":201,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Sequential growth of 110,500 patients, or over 22 percent, in CenterWell Senior Primary Car...